Outfitter Financial’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-18,528
Closed -$1.5M 84
2023
Q4
$1.5M Buy
18,528
+50
+0.3% +$3.89K 1.31% 32
2023
Q3
$1.38M Sell
18,478
-35
-0.2% -$2.69K 1.3% 33
2023
Q2
$1.43M Sell
18,513
-30
-0.2% -$2.39K 1.28% 33
2023
Q1
$1.54M Sell
18,543
-215
-1% -$17.8K 1.39% 29
2022
Q4
$1.61M Sell
18,758
-67
-0.4% -$5.31K 1.46% 24
2022
Q3
$1.16M Hold
18,825
1.14% 35
2022
Q2
$1.16M Sell
18,825
-400
-2% -$24.8K 1.06% 40
2022
Q1
$1.14M Hold
19,225
0.87% 49
2021
Q4
$1.4M Sell
19,225
-145
-0.7% -$9.99K 1.02% 39
2021
Q3
$1.35M Buy
19,370
+110
+0.6% +$7.73K 1.06% 38
2021
Q2
$1.33M Sell
19,260
-130
-0.7% -$8.68K 1.02% 40
2021
Q1
$1.25M Buy
19,390
+2,110
+12% +$136K 1.03% 39
2020
Q4
$967K Buy
+17,280
New +$1.04M 0.93% 42

Other funds holding GILD

Outfitter Financial's GILD Position: Q1 2024 in Review

Outfitter Financial sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 18,528 shares — an estimated $1.5M sold.

Outfitter Financial first reported a position in GILD in Q4 2020 and held it in 13 quarters. The position peaked at $1.61M in Q4 2022. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Outfitter Financial reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Outfitter Financial sold 18,528 Gilead Sciences shares in Q1 2024, an estimated $1.5M.
  • Outfitter Financial first reported a position in Gilead Sciences in Q4 2020 and held it in 13 quarters.
  • Outfitter Financial's Gilead Sciences position peaked at $1.61M in Q4 2022.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Outfitter Financial's 13F filing for Q1 2024, filed 30 Apr 2024.